There are 412 resources available
1472P - Radiotherapy affects immunotherapy efficacy based on tumor mutation status in patients with metastatic NSCLC
Presenter: Shenduo Li
Session: Poster session 21
1283P - Predicting PD-L1 expression using [18F]FDG PET/CT in early stage non-small cell lung cancer (NSCLC)
Presenter: Daniel Hughes
Session: Poster session 04
The role of surgery
Presenter: Giulia Veronesi
Session: Management of oligometastatic disease in NSCLC
Resources:
Slides
Webcast
1265P - Toripalimab plus chemotherapy as neoadjuvant treatment for resectable stage IIB-IIIB NSCLC (RENAISSANCE study): A single-arm, phase II trial
Presenter: Shi Yan
Session: Poster session 04
1346P - Efficacy and safety of high dose furmonertinib combined with intrathecal injection in EGFR-mutated advanced NSCLC patients with LM progressed on osimertinib
Presenter: Xiaoyan Li
Session: Poster session 19
Discussion
Presenter: All Speakers
Session: Adjuvant / neoadjuvant therapy of operable NSCLC in 2023
Resources:
Slides
Webcast
Q&A and Discussion
Presenter: All Speakers
Session: Management of oligometastatic disease in NSCLC
Resources:
Slides
Webcast
Predictive biomarkers for adjuvant / neoadjuvant IO
Presenter: Nicolas Girard
Session: Adjuvant / neoadjuvant therapy of operable NSCLC in 2023
Resources:
Webcast
60P - Establishment and characterization of a novel lung adenocarcinoma cell line HX-JCJ harboring MET ex14 skipping mutation
Presenter: Xuejin Ou
Session: Poster session 09